• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Quertle, Elsevier collaborate to integrate full-text searching with artificial intelligence discovery tool

Quertle, Elsevier collaborate to integrate full-text searching with artificial intelligence discovery tool

February 8, 2017
CenterWatch Staff

Henderson, Nevada-based Quertle, developer of the first artificial intelligence (AI) biomedical big data discovery platform (BioAI) for biomedical literature, and Amsterdam-based Elsevier, a provider of scientific, technical and medical information products and services, announce that full-text searching of biomedical and life science content on ScienceDirect, Elsevier’s information source with over 14 million publications, will be integrated into Quertle’s artificial intelligence discovery product Qinsight.

Because traditional search methods often produce long lists of irrelevant results, users can be overwhelmed and miss pertinent documents. Semantics, natural language processing and other current AI-based methods fail to address this issue and meet researcher needs. In contrast, Qinsight uses biomedically-optimized neural networks and other AI methods to simulate how an expert’s brain discovers the most relevant information, discerns critical facts and discovers key concepts. Qinsight also provides advanced visual analytics to summarize results, predict trends and discover hidden connections within the literature. The ScienceDirect content will provide a significant expansion to the more than 40 million authoritative documents, which includes more than 10 million full-text documents, already searched in Qinsight.

“Searching the full text of ScienceDirect using Quertle’s BioAI-based discovery and visual analytics methods will allow Qinsight users to recognize a greater value from their Elsevier holdings,” said Jeff Saffer, Quertle president and CEO.

“We are excited to work with Quertle, providing our biomedical and life science content to help Qinsight users find what matters and guide them to the relevant full-text articles on ScienceDirect. This will help their research to move faster and empower knowledge in the medical and scientific community,” said Laura Hassink, senior vice president for ScienceDirect product management at Elsevier.

The full-text content from ScienceDirect is projected to be searchable in Qinsight in the first quarter of 2017 as an add-on module to every Qinsight subscription. Users from institutions with ScienceDirect subscriptions will also be able to view non-open access full-text documents.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing